PHARMACYCLICS INC Costs and Expenses
PHARMACYCLICS INC reported Costs and Expenses of $201.99 million for the 3-month period ending 2015-03-31, per its 10-Q filed 2015-05-04.
Discontinued › Expense Statement › Operating Expenses
us-gaap:CostsAndExpenses · last filed 2015-05-04
- PHARMACYCLICS INC costs and expenses for the quarter ending 2015-03-31 was $201.99M, a 99.69% increase year-over-year.
- PHARMACYCLICS INC costs and expenses for the quarter ending 2014-12-31 was $197.20M, a 417.32% increase year-over-year.
- PHARMACYCLICS INC costs and expenses for the quarter ending 2014-09-30 was $158.77M, a 518.70% increase year-over-year.
- PHARMACYCLICS INC costs and expenses for the quarter ending 2014-06-30 was $150.22M, a 252.20% increase year-over-year.
- PHARMACYCLICS INC costs and expenses for fiscal 2014 was $607.35M, a 274.34% increase from fiscal 2013.
- PHARMACYCLICS INC costs and expenses for fiscal 2013 was $162.25M.
- PHARMACYCLICS INC costs and expenses for fiscal 2012 was $70.11M, a 60.78% increase from fiscal 2011.
- PHARMACYCLICS INC costs and expenses for fiscal 2011 was $43.61M.
| Period end | Costs and Expenses 3 month | Costs and Expenses 6 month | Costs and Expenses 9 month | Costs and Expenses 12 month |
|---|---|---|---|---|
| 2015-03-31 | $201.99M 10-Q · filed 2015-05-04 | $399.19M derived: sum of 2 quarters · filed 2015-05-04 | $557.96M derived: sum of 3 quarters · filed 2015-05-04 | $708.19M derived: sum of 4 quarters · filed 2015-05-04 |
| 2014-12-31 | $197.20M 10-K · filed 2015-02-18 | $355.97M derived: sum of 2 quarters · filed 2015-02-18 | $506.20M derived: sum of 3 quarters · filed 2015-02-18 | $607.35M 10-K · filed 2015-02-18 |
| 2014-09-30 | $158.77M 10-K · filed 2015-02-18 | $309.00M derived: sum of 2 quarters · filed 2015-02-18 | $410.15M 10-Q · filed 2014-11-07 | $448.27M derived: sum of 4 quarters · filed 2015-05-04 |
| 2014-06-30 | $150.22M 10-K · filed 2015-02-18 | $251.38M 10-Q · filed 2014-08-08 | $289.50M derived: sum of 3 quarters · filed 2015-05-04 | $315.16M derived: sum of 4 quarters · filed 2015-05-04 |
| 2014-03-31 | $101.15M 10-Q · filed 2015-05-04 | $139.27M derived: sum of 2 quarters · filed 2015-05-04 | $164.93M derived: sum of 3 quarters · filed 2015-05-04 | $207.59M derived: sum of 4 quarters · filed 2015-05-04 |
| 2013-12-31 | $38.12M 10-K · filed 2015-02-18 | $63.78M derived: sum of 2 quarters · filed 2015-02-18 | $106.44M derived: sum of 3 quarters · filed 2015-02-18 | $162.25M 10-K · filed 2015-02-18 |
| 2013-09-30 | $25.66M 10-K · filed 2015-02-18 | $68.31M derived: sum of 2 quarters · filed 2015-02-18 | $124.13M 10-Q · filed 2014-11-07 | $140.79M derived: sum of 4 quarters · filed 2015-02-18 |
| 2013-06-30 | $42.65M 10-K · filed 2015-02-18 | $98.46M 10-Q · filed 2014-08-08 | $115.13M derived: sum of 3 quarters · filed 2015-02-18 | $139.07M derived: sum of 4 quarters · filed 2015-02-18 |
| 2013-03-31 | $55.81M 10-K · filed 2015-02-18 | $72.48M derived: sum of 2 quarters · filed 2015-02-18 | $96.42M derived: sum of 3 quarters · filed 2015-02-18 | $116.02M derived: sum of 4 quarters · filed 2015-02-18 |
| 2012-12-31 | $16.67M 10-K · filed 2014-02-26 | $40.61M 10-K · filed 2015-02-18 | $60.21M derived: sum of 3 quarters · filed 2014-02-26 | $80.10M derived: sum of 4 quarters · filed 2014-02-26 |
| 2012-09-30 | $23.94M 10-K · filed 2014-02-26 | $43.55M derived: sum of 2 quarters · filed 2014-02-26 | $63.43M derived: sum of 3 quarters · filed 2014-02-26 | |
| 2012-06-30 | $19.61M 10-K · filed 2014-02-26 | $39.49M derived: sum of 2 quarters · filed 2014-02-26 | $70.11M 10-K · filed 2015-02-18 | |
| 2012-03-31 | $19.89M 10-K · filed 2014-02-26 | |||
| 2011-12-31 | $30.62M 10-K · filed 2015-02-18 | |||
| 2011-06-30 | $43.61M 10-K · filed 2014-02-26 |